North Star Investment Management Corp. grew its holdings in shares of Psychemedics Corp. (NASDAQ:PMD) by 3.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 81,150 shares of the company’s stock after buying an additional 2,879 shares during the period. North Star Investment Management Corp. owned 1.48% of Psychemedics worth $1,668,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in PMD. JPMorgan Chase & Co. lifted its holdings in Psychemedics by 8.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 16,564 shares of the company’s stock worth $413,000 after buying an additional 1,345 shares during the last quarter. LSV Asset Management lifted its holdings in Psychemedics by 193.4% during the 2nd quarter. LSV Asset Management now owns 26,404 shares of the company’s stock worth $658,000 after buying an additional 17,404 shares during the last quarter. AJO LP purchased a new stake in Psychemedics during the 2nd quarter worth about $832,000. Ativo Capital Management LLC purchased a new stake in Psychemedics during the 2nd quarter worth about $1,423,000. Finally, Northern Trust Corp lifted its holdings in shares of Psychemedics by 96.5% in the 2nd quarter. Northern Trust Corp now owns 38,227 shares of the company’s stock valued at $953,000 after purchasing an additional 18,778 shares during the last quarter. 57.35% of the stock is owned by institutional investors.

Shares of Psychemedics Corp. (PMD) opened at $21.66 on Friday. Psychemedics Corp. has a fifty-two week low of $13.81 and a fifty-two week high of $27.99. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.72 and a quick ratio of 2.72. The firm has a market capitalization of $118.96, a PE ratio of 19.51 and a beta of 0.95.

Psychemedics (NASDAQ:PMD) last posted its earnings results on Tuesday, October 24th. The company reported $0.25 earnings per share for the quarter. Psychemedics had a return on equity of 37.33% and a net margin of 15.06%. The business had revenue of $10.05 million during the quarter.

Separately, BidaskClub raised Psychemedics from a “sell” rating to a “hold” rating in a report on Saturday, November 4th.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/psychemedics-corp-pmd-holdings-increased-by-north-star-investment-management-corp/1804029.html.

Psychemedics Profile

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.

Institutional Ownership by Quarter for Psychemedics (NASDAQ:PMD)

Receive News & Ratings for Psychemedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics and related companies with Analyst Ratings Network's FREE daily email newsletter.